DHS Biodetection Improvement Act
Key claim: The DHS Biodetection Improvement Act directs DHS to assess its utilization of Department of Energy national laboratories for R&D and to report to Congress a strategy for coordinated biodetection research and development.
Abstract
(HR706 · 119th Congress) DHS Biodetection Improvement Act This bill directs the Department of Homeland Security (DHS) to assess how it has utilized Department of Energy national laboratories and sites for research and development in carrying out DHS missions and to report to Congress a strategy for how DHS will conduct biodetection research and development in coordination with such laboratories and sites. Latest action (2025-03-12): Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Why this matters
Biodetection R&D at DHS has historically been fragmented across S&T, CWMD, and interagency partners including DOE national laboratories; this bill imposes an oversight step requiring DHS to inventory its national-lab utilization and deliver a coordinated strategy. The practical implication is procedural — no new funding or authorities — but the resulting strategy could shape how future biodefense investments and interagency lab work are structured.